Suppr超能文献

伴肺动脉高压的烟雾病中的无名指蛋白213:一篇综述

Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review.

作者信息

Luo Yuting, Cao Zhixin, Wu Shaoqing, Sun Xunsha

机构信息

Department of Neurology, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

出版信息

Front Neurol. 2022 Mar 24;13:843927. doi: 10.3389/fneur.2022.843927. eCollection 2022.

Abstract

Moyamoya disease (MMD), most often diagnosed in children and adolescents, is a chronic cerebrovascular disease characterized by progressive stenosis at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain. Recently, many investigators show a great interest in MMD with pulmonary arterial hypertension (PAH). is a major susceptibility gene for MMD and also has strong correlations with PAH. Therefore, this review encapsulates current cases of MMD with PAH and discusses MMD with PAH in the aspects of epidemiology, pathology, possible pathogenesis, clinical manifestations, diagnosis, and treatment.

摘要

烟雾病(MMD)最常发生于儿童和青少年,是一种慢性脑血管疾病,其特征为颈内动脉末端进行性狭窄以及脑底部异常血管网形成。最近,许多研究者对合并肺动脉高压(PAH)的烟雾病表现出极大兴趣。 是烟雾病的一个主要易感基因,也与肺动脉高压密切相关。因此,本综述总结了目前合并肺动脉高压的烟雾病病例,并从流行病学、病理学、可能的发病机制、临床表现、诊断及治疗等方面对合并肺动脉高压的烟雾病进行了探讨。

相似文献

1
Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review.
Front Neurol. 2022 Mar 24;13:843927. doi: 10.3389/fneur.2022.843927. eCollection 2022.
3
A histopathological report of a 16-year-old male with peripheral pulmonary artery stenosis and Moyamoya disease with a homozygous mutation.
Respir Med Case Rep. 2019 Dec 14;29:100977. doi: 10.1016/j.rmcr.2019.100977. eCollection 2020.
4
Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
Transl Stroke Res. 2020 Aug;11(4):580-589. doi: 10.1007/s12975-019-00743-6. Epub 2019 Oct 24.
5
Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
J Neurosurg. 2016 May;124(5):1221-7. doi: 10.3171/2015.4.JNS142900. Epub 2015 Oct 2.
7
[Precision Medicine for Moyamoya Disease].
No Shinkei Geka. 2022 Jan;50(1):216-221. doi: 10.11477/mf.1436204546.
9
Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.
J Heart Lung Transplant. 2020 Feb;39(2):103-112. doi: 10.1016/j.healun.2019.08.022. Epub 2019 Sep 2.
10
RNF213 rare variants in an ethnically diverse population with Moyamoya disease.
Stroke. 2014 Nov;45(11):3200-7. doi: 10.1161/STROKEAHA.114.006244. Epub 2014 Oct 2.

引用本文的文献

1
-Related Vasculopathy: An Entity with Diverse Phenotypic Expressions.
Genes (Basel). 2025 Aug 7;16(8):939. doi: 10.3390/genes16080939.
2
RNF213 regulates blood‒brain barrier integrity by targeting TRAF3 for type I interferon activation during A. baumannii infection.
PLoS Pathog. 2025 Jul 7;21(7):e1013333. doi: 10.1371/journal.ppat.1013333. eCollection 2025 Jul.
3
RNF213 vasculopathy manifested in various forms within a family: A case report.
Medicine (Baltimore). 2023 Dec 15;102(50):e36627. doi: 10.1097/MD.0000000000036627.

本文引用的文献

2
Moyamoya disease associated with pediatric pulmonary hypertension-a case report.
Cardiovasc Diagn Ther. 2021 Aug;11(4):1052-1056. doi: 10.21037/cdt-20-249.
3
RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability.
Front Neurol. 2021 Jul 26;12:687088. doi: 10.3389/fneur.2021.687088. eCollection 2021.
4
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.
Curr Neuropharmacol. 2022;20(2):292-308. doi: 10.2174/1570159X19666210716114016.
5
Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105965. doi: 10.1016/j.jstrokecerebrovasdis.2021.105965. Epub 2021 Jul 8.
6
Arterial Wall Stiffening in Caveolin-1 Deficiency-Induced Pulmonary Artery Hypertension in Mice.
Exp Mech. 2021 Jan;6(1):217-228. doi: 10.1007/s11340-020-00666-6. Epub 2020 Oct 14.
7
Association of De Novo Variants With Childhood Onset Moyamoya Disease and Diffuse Occlusive Vasculopathy.
Neurology. 2021 Mar 30;96(13):e1783-e1791. doi: 10.1212/WNL.0000000000011653. Epub 2021 Feb 10.
8
PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
Circ Res. 2021 Feb 5;128(3):401-418. doi: 10.1161/CIRCRESAHA.119.316339. Epub 2020 Dec 16.
10
Prospective Screening of Extracranial Systemic Arteriopathy in Young Adults with Moyamoya Disease.
J Am Heart Assoc. 2020 Oct 20;9(19):e016670. doi: 10.1161/JAHA.120.016670. Epub 2020 Sep 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验